Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: Topographical evaluation of the IGF-2/IGFBP-2 and IGFBP-3 interface

被引:11
作者
Robinson, SA
Rosenzweig, SA
机构
[1] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA
关键词
D O I
10.1021/bi049082k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the insulin-like growth factor-1 (IGF)-1 receptor signaling pathways by IGF-1 and IGF-2 results in mitogenic and anabolic effects. The bioavailability of the IGFs is regulated by six soluble binding proteins, the insulin-like growth factor binding proteins (IGFBPs), which bind with similar to0.1 nM affinity to the IGFs and often serve as endogenous antagonists of IGF action. To identify key domains of IGF-1 involved in the interaction with IGFBP-2 and IGFBP-3, we employed IGF-1 selectively biotinylated on residues Gly 1, Lys 27, Lys 65, and Lys 68. All monobiotinylated species of IGF-1 exhibited high affinity (similar to0.1-0.2 nM) for IGFBP-2 and IGFBP-3 in solid-phase-binding assays. However, different labeling intensities were observed in ligand blot analysis of IGFBP-2 and IGFBP-3. The N-epsilonLys65/68(biotin)-IGF-1 (N-epsilonLys65/68b-IGF-1) probe exhibited the highest signal intensity, while N-alphaGly1b-IGF-1 and N-epsilonLys27b-IGF-1 demonstrated significantly lower signals. When taken together, these results suggest that, once bound to IGFBP-2 or IGFBP-3, the biotin moieties of N-alphaGly1b-IGF-1 and N-epsilonLys27b-IGF-1 are inaccessible to NeutrAvidin-peroxidase, the secondary binding component. Ligand blots using IGF-1 derivatized with a long chain form of the N-hydroxysuccinimide biotin (NHS-biotin) to yield N-alphaGly1(LC-biotin)-IGF-1 and N-epsilonFLys27(LC-biotin)-IGF-1 demonstrated increased signal intensity compared with their NHS-biotin counterparts. In BIAcore analysis, IGFBP-2 and IGFBP-3 bound only to the N-epsilonLys65/68b-IGF-1-coated flowcell of a biosensor chip, confirming the inaccessibility of Gly 1 and Lys 27 when IGF-1 is bound to IGFBP-2 and IGFBP-3. These data confirm the involvement of the IGFBP-binding domain on IGF-1 in binding to IGFBP-2 and IGFBP-3 and support involvement of the IGF-1R-binding domain in IGFBP binding.
引用
收藏
页码:11533 / 11545
页数:13
相关论文
共 60 条
[31]   Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I [J].
Horney, MJ ;
Shirley, DW ;
Kurtz, DT ;
Rosenzweig, SA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (06) :F1045-F1053
[32]   Synthesis and characterization of insulin-like growth factor (IGF)-1 photoprobes selective for the IGF-binding proteins (IGFBPs) - Photoaffinity labeling of the IGF-binding domain on IGFBP-2 [J].
Horney, MJ ;
Evangelista, CA ;
Rosenzweig, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2880-2889
[33]   ANALYSIS OF SERUM INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS USING WESTERN BLOTTING - USE OF THE METHOD FOR TITRATION OF THE BINDING-PROTEINS AND COMPETITIVE-BINDING STUDIES [J].
HOSSENLOPP, P ;
SEURIN, D ;
SEGOVIAQUINSON, B ;
HARDOUIN, S ;
BINOUX, M .
ANALYTICAL BIOCHEMISTRY, 1986, 154 (01) :138-143
[34]   INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II [J].
HUMBEL, RE .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 190 (03) :445-462
[35]   The insulin-like growth factor-binding protein (IGFBP) superfamily [J].
Hwa, V ;
Oh, Y ;
Rosenfeld, RG .
ENDOCRINE REVIEWS, 1999, 20 (06) :761-787
[36]   Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture [J].
Imai, Y ;
Busby, WH ;
Smith, CE ;
Clarke, JB ;
Garmong, AJ ;
Horwitz, GD ;
Rees, C ;
Clemmons, DR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2596-2605
[37]   Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and-5 markedly reduce IGF-I binding and alter their biologic actions [J].
Imai, Y ;
Moralez, A ;
Andag, U ;
Clarke, JB ;
Busby, WH ;
Clemmons, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18188-18194
[38]   INSULIN-LIKE GROWTH-FACTORS AND THEIR BINDING-PROTEINS - BIOLOGICAL ACTIONS [J].
JONES, JI ;
CLEMMONS, DR .
ENDOCRINE REVIEWS, 1995, 16 (01) :3-34
[39]   Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions [J].
Kalus, W ;
Zweckstetter, M ;
Renner, C ;
Sanchez, Y ;
Georgescu, J ;
Grol, M ;
Demuth, D ;
Schumacher, R ;
Dony, C ;
Lang, K ;
Holak, TA .
EMBO JOURNAL, 1998, 17 (22) :6558-6572
[40]   Insulin-like growth factor-I inhibits cell growth in the A549 non-small lung cancer cell line [J].
Kodama, Y ;
Baxter, RC ;
Martin, JL .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (03) :336-344